{"id":"W2180558964","doi":"10.1055/s-0037-1617033","title":"Factor Xa inhibitors","year":2009,"lang":"en","type":"article","venue":"Hämostaseologie","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Rivaroxaban; Apixaban; Medicine; Edoxaban; Drug; Pharmacodynamics; Fondaparinux; Anticoagulant; Pharmacology; Clinical trial; Pharmacokinetics; Knee replacement; Intensive care medicine; Internal medicine; Venous thromboembolism; Warfarin; Surgery; Arthroplasty; Thrombosis; Atrial fibrillation","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006518991,0.00009801795,0.0001748345,0.00007576255,0.00004513779,0.00001181442,0.00004438194,0.00006442881,0.0005890452],"category_scores_gemma":[0.0001987923,0.00007478859,0.0001009449,0.0001474173,0.00002780094,0.00006424235,0.0000225067,0.00007208911,0.0003252343],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003292318,"about_ca_system_score_gemma":0.00002381146,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002969835,"about_ca_topic_score_gemma":5.479508e-7,"domain_scores_codex":[0.9993322,0.00001495172,0.0001650259,0.0001519898,0.0001502133,0.0001855452],"domain_scores_gemma":[0.999613,0.00004806529,0.00004219027,0.0001897351,0.00003008261,0.00007694247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003847462,0.00003404382,0.6650637,0.00003061721,0.0000700715,0.0002016529,0.0001452434,0.00001630684,0.007040359,0.006339389,0.08683937,0.2338345],"study_design_scores_gemma":[0.001303318,0.0004106367,0.7016857,0.00001743994,0.00005427586,0.000008391431,0.00007806078,0.00004293875,0.007386172,0.001137509,0.2877042,0.0001713672],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9411027,0.000359305,0.0003163404,0.03010156,0.000507303,0.0004898122,0.000009501624,0.0004650062,0.02664842],"genre_scores_gemma":[0.9927543,0.00004234755,0.0008388075,0.001848043,0.0005463639,4.299278e-7,0.00003924271,0.000005786632,0.003924616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2336631,"threshold_uncertainty_score":0.6449632,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1260128776701787,"score_gpt":0.3735269286596272,"score_spread":0.2475140509894485,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}